Sexual Dysfunction in Gynecologic Oncology Patients
Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This project will evaluate sexual dysfunction in women who have had surgery for gynecologic
cancer. The subjects will complete a set of questionnaires about health, daily living, sexual
encounters, and pain before their surgery and three times following. Each subject will be
randomized to receive either lidocaine or a placebo that is applied vaginally immediately
prior to any sexual encounters for approximately 6 months while maintaining a journal of
sexual encounters and pain. The subjects and healthcare providers will be blinded to the
treatment randomization until intervention and data collection is complete. Total
participation will last up to one year from the date of enrollment. Subjects will visit the
clinic at the same time as regular cancer care visits, receive the blinded intervention and
complete the surveys.